Chronic Pain Clinical Trial
Official title:
Intra-epidermal Nerve Fibre Density and Its Relationship to Post-caesarean Section Pain
Chronic pain is a significant burden to the individual and society with post-surgical pain
identified as a research priority for the speciality of anaesthesia.
The objectives are to explore the relationship between IENFD and pain after caesarean section
and to explore the characteristics of post-caesarean section pain.
The hypothesis is that reduced pre-operative IENFD at the surgical site will correlate with
risk of developing CPSP.
Based on the existing evidence, chronic pain after caesarean section appears to have an
incidence between 12-18%; with the current Scottish caesarean section rate, this equates to
approximately 3000 young, active women each year. Their lives may be affected by pain leading
to increased analgesic use, a restriction of daily activities, decreased quality of life, and
increased utilisation of healthcare services. The National Institute of Academic Anaesthesia
(NIAA) has undertaken a priority setting exercise with 1700 patients and clinicians and
declared the prevention of chronic post-surgical pain as one of its top 10 research
priorities for the speciality of Anaesthesia.
IENFD is calculated by counting the number of nerve fibres crossing the basement membrane
through direct visualisation of a skin biopsy that has undergone immunohistochemical
staining. Skin biopsy is minimally invasive and allows visualisation of small fibre
nociceptors that are not suitable for identification or study through nerve conduction
studies.
There is emerging evidence from clinical studies that chemotherapy induced peripheral
neuropathy (CIPN) patients have altered sensory innervation compared to healthy controls. In
both colorectal cancer and multiple myeloma, pre-oncological treatment reductions in IENFD
were associated with changes in physical testing, confirming a subclinical sensory deficit.
The degree of loss of IENFD correlates with development of mechanical hyperalgesia and
patients with greater sensory loss at baseline developed more symptoms during and after
chemotherapy. To date there have been no studies that have examined the relationship between
a patient's pre-operative IENFD and the development of chronic post-surgical pain.
This single cohort observational study shall recruit women undergoing elective caesarean
section within the Simpson's Centre for Reproductive Health (SCRH). All women shall be sent a
patient information sheet with a covering letter one week prior to the date of the surgery.
There shall be five discrete data collection points:
- Before caesarean section: a researcher shall collect patient demographic data,
information about their general health and ask the patient to complete a Hospital
Anxiety & Depression Scale (HADS).
- At the time of caesarean section: a punch biopsy shall be taken from the incision site
and be sent for INEFD testing. This will be carried out once surgical anaesthesia has
been achieved thereby not causing any discomfort to the participant.
- 24 hours post caesarean section: The patient's electronic record shall be consulted, if
there has been any traumatic events (e.g. death or significant injury to the baby) then
we shall remove the patient from the study to prevent causing any further emotional
distress. The participant will be informed of this.
A researcher shall ask the patient to complete the BPI (omitting section 9 that is
non-applicable).
• 3 & 6 months post caesarean section: The patient's electronic record shall be consulted, if
there has been any traumatic events (e.g. death or significant injury to the baby) then we
shall remove the patient from the study to prevent causing any further emotional distress.
The participant will be informed of this.
A researcher shall contact participants by phone and, if they have pain, ask them to complete
the following questionnaires: HADS, BPI and S-LANSS.
A researcher shall attempt to contact the patient twice via telephone, leaving a message if
able, but if there is no answer or response then an assumption will be made that the
participant wishes to longer be involved. No further attempts at contact will be made.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01659073 -
Using Perfusion MRI to Measure the Dynamic Changes in Neural Activation Associated With Caloric Vestibular Stimulation
|
N/A | |
Recruiting |
NCT05914311 -
Use of Dermabond in Mitigation of Spinal Cord Stimulation (SCS) Trial Lead Migration
|
N/A | |
Recruiting |
NCT05422456 -
The Turkish Version of Functional Disability Inventory
|
||
Enrolling by invitation |
NCT05422443 -
The Turkish Version of Pain Coping Questionnaire
|
||
Completed |
NCT05057988 -
Virtual Empowered Relief for Chronic Pain
|
N/A | |
Completed |
NCT04385030 -
Neurostimulation and Mirror Therapy in Traumatic Brachial Plexus Injury
|
N/A | |
Recruiting |
NCT06206252 -
Can Medical Cannabis Affect Opioid Use?
|
||
Completed |
NCT05103319 -
Simultaneous Application of Ketamine and Lidocaine During an Ambulatory Infusion Therapy as a Treatment Option in Refractory Chronic Pain Conditions
|
||
Completed |
NCT03687762 -
Back on Track to Healthy Living Study
|
N/A | |
Completed |
NCT04171336 -
Animal-assisted Therapy for Children and Adolescents With Chronic Pain
|
N/A | |
Completed |
NCT03179475 -
Targin® for Chronic Pain Management in Patients With Spinal Cord Injury
|
Phase 4 | |
Completed |
NCT03418129 -
Neuromodulatory Treatments for Pain Management in TBI
|
N/A | |
Completed |
NCT03268551 -
MEMO-Medical Marijuana and Opioids Study
|
||
Recruiting |
NCT06060028 -
The Power of Touch. Non-Invasive C-Tactile Stimulation for Chronic Osteoarthritis Pain
|
N/A | |
Recruiting |
NCT06204627 -
TDCS* and Laterality Trainnning in Patients With Chronic Neck Pain
|
N/A | |
Completed |
NCT05496205 -
A SAD Study to Evaluate the Safety, Tolerability and PK/PD of iN1011-N17 in Healthy Volunteers
|
Phase 1 | |
Completed |
NCT00983385 -
Evaluation of Effectiveness and Tolerability of Tapentadol Hydrochloride in Subjects With Severe Chronic Low Back Pain Taking Either WHO Step I or Step II Analgesics or no Regular Analgesics
|
Phase 3 | |
Recruiting |
NCT05118204 -
Randomized Trial of Buprenorphine Microdose Inductions During Hospitalization
|
Phase 4 | |
Terminated |
NCT03538444 -
Repetitive Transcranial Magnetic Stimulation for Opiate Use Disorder
|
N/A | |
Not yet recruiting |
NCT05812703 -
Biometrics and Self-reported Health Changes in Adults Receiving Behavioral Treatments for Chronic Pain
|